Careers
Contact us
About us
Message from the President
Why choose ICTA?
International coverage
ICTA team
Services
Design
Regulatory affairs
Project management
Site Support
Risk-based monitoring
Vigilance
Data management
Biostatistics
Medical writing
Areas of expertise
Clinical development
Early access
Real World Evidence
Health data analysis
Biotech
Medical device
Decentralised studies
Therapeutic areas
Case studies
IT Platform
IT tools
Secured IT collaborative platform
Latest news
Where to meet us
Scientific publications
Careers
Contact us
Case studies
In this selection of case studies, find out the bespoke, creative solutions we implemented
to turn project challenges into successes.
Open, non-controlled, parallel cohorts, multicenter, phase 2a trial for the evaluation of the antitumor activity of an IMP single agent and in combination with chemotherapy in patients with locally advanced or metastatic colorectal cancer.
Read case study
A First-In-Human trial of monoclonal antibody IMP in patients with Anti-Müllerian-Hormone-Receptor II (AMHRII) positive gynecological cancers
Read case study
Lung cancer patients treated with a new PD-1 IMP: A longitudinal, prospective, observational, multicentric study in France
Read case study
A Prospective study on an IMP PET/CT Imaging in Biochemical Recurrence of Prostate Cancer
Read case study
Pain relief and protection of three self-treated dermatological foot conditions
Read case study
Open, non-controlled, parallel cohorts, multicenter, phase 2a trial for the evaluation of the antitumor activity of an IMP single agent and in combination with chemotherapy in patients with locally advanced or metastatic colorectal cancer.
Read case study
Derived cell ATMP implantation for the treatment of fecal incontinence: a multicentre, randomized, double-blind, placebo-controlled, parallel-group, dose-finding clinical study.
Read case study
A phase 1/2, open-label, safety, tolerability and preliminary efficacy study of implantation into one eye of an ATMP in patients with retinitis pigmentosa due to monogenic mutation
Read case study
Long-Term Safety Evaluation of a Medicinal Product in Inherited Haematological Disorder in Europe
Read case study
Prevention & Treatment of a non-serious dermatological condition on the foot
Read case study